Tag Archives: Reuters

What’s wrong with Novartis? Actually nothing.






The News: Novartis AG (Basel CHE) has been the subject of widespread and lingering chatter to the effect that its stature among the Big Pharma league players has diminished, and… Read more »

Puma doubles on FDA panel’s nod for breast-cancer drug; but Swiss giant’s challenger lurks






The News: Puma Biotechnology Inc.’s (Los Angeles) experimental breast cancer drug reduces the risk of disease recurrence and should be approved, an advisory committee to the US Food and Drug… Read more »

Amgen’s osteoporosis med almost a home run in latest trial; fate now murky on heart safety






The News: Amgen Inc. (Thousand Oaks CA) and UCB SA (Brussels) no longer expect their experimental osteoporosis drug to win US approval this year after a higher rate of serious… Read more »

Surprise! GOP health bill never left the House






The News: The US House of Representatives will send its healthcare overhaul plan passed earlier this month to the Senate in a couple of weeks after it receives a final… Read more »

Merck’s Keytruda gets chemo-combo approval for lung cancer; science, stars align for multi-billion medicine






The News: Merck & Co. announced Wednesday (May 10, 2017) that the FDA awarded accelerated approval to Keytruda (pembrolizumab), in combination with Eli Lilly & Co.’s chemotherapy regimen Alimta (pemetrexed)… Read more »

Molina Healthcare sacks founder’s sons; but don’t bet on a takeout






The News: Molina Healthcare Inc. (Long Beach CA) has fired its two top executives, sons of the medium-sized health insurer’s founder, in a surprise shakeup prompted by its poor financial… Read more »

Zombie Trumpcare doesn’t make it to Congress again despite Republican insistence it outshines first train wreck






After an embarrassing failure in March, with President Donald Trump pushing fellow Republicans in the US Congress to try again to replace his predecessor’s healthcare reform, US House leaders decided… Read more »

Anthem defies Wall Street, rivals, with stellar 1Q results pegged to Obamacare business






The News: Anthem Inc. (Indianapolis IN), which has 1.1 million customers in individual Obamacare plans, said it was moving ahead with its 2018 insurance filings but had told state regulators… Read more »

Novartis 1Q results remain insomnia cure; investors plead for something, anything to get excited about






The News: Novartis AG shares moved higher Tuesday (April 25, 2017) after the pharmaceuticals group clung to full-year earnings targets and barely beat analysts’ estimates for first-quarter earnings. The Swiss… Read more »

China’s FDA approves AstraZeneca’s lung-cancer drug in new “fast-track” program; European drugmakers beating US to world’s biggest drug market






The News: AstraZeneca PLC (London) has won approval for its lung-cancer pill Tagrisso in China, a key market for the potential blockbuster medicine. Tagrisso is designed to help cancer patients… Read more »